Yellow Fever Outbreak Toolbox

Yellow Fever Outbreak Toolbox

Updated | March 2024

WHO/E. Soteras Jalil
© Credits

Welcome to the Yellow Fever Outbreak Toolbox

Key reference documents

Case definitions

WHO suggested outbreak case definition1

Suspected case:

Any person with acute onset of fever, with jaundice appearing within 14 days of onset of the first symptoms.

Confirmed case:

1. A probable case; and 
Absence of yellow fever immunization within 30 days before onset of illness; and one of the following:  

  • detection of yellow fever-specific IgM;2or 
  • detection of fourfold increase in yellow fever IgM, or IgG antibody titres between acute and convalescent serum samples, or both; or 
  • detection of yellow fever-specific neutralizing antibodies.  

or

2. Absence of yellow fever immunization within 14 days before onset of illness; and one of the following: 
  • detection of yellow fever virus genome in blood or other organs by polymerase chain reaction (PCR); or
  • detection of yellow fever antigen in blood, liver or other organs by immunoassay; or 
  • isolation of yellow fever virus.

WHO surveillance case definition

WHO other definitions 

Outbreak definitions: 

  • Presence of at least one confirmed case of yellow fever, as interpreted in a context of underlying population immunity and risk of onward amplification.


1. Yellow Fever: Vaccine Preventable Diseases Surveillance Standards (Geneva: World Health Organization; 2020)

2. Yellow fever-specific means that the results of antibody tests (such as IgM or neutralizing antibody) for other prevalent flavivirues are negative or not significant. Testing should include at least IgM for dengue fever and West Nile but may include other flaviviruses according to local epidemiology (for example, Zika virus).

3. Yellow fever confirmation is complex:

  • Any case classification should account for vaccination status.
  • Serological testing cannot distinguish between vaccine- and naturally-acquired antibodies.
  • Yellow fever diagnostic is both positive and differential. It is essential to rule out cross-reactivity with other arboviruses such as dengue, zika, chikungunya or West Nile virus This cross-reactivity can be seen on serology testing (IgM) as well as plague reduction neutralization assays (PRNT).
    Results should be interpreted considering local epidemiology of other flaviviruses.

 

Data collection tools

Laboratory confirmation

Response tools and resources

Training

Other resources